Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome

Article ID	Journal	Published Year	Pages	File Type
8466244	Cytokine & Growth Factor Reviews	2018	48 Pages	PDF

Keywords

Bcl-2 homologous antagonist/killer IL-10 TLR CCL20 DR5 MIP-3α PRR PKR PRRs DCs SOCS3 CPSF6 BST-2 IFI16 LCMV SAMHD1 JAK-STAT RIG1 2′-5′-oligoadenylate synthetase NF-κB chemokine (C-C motif) ligand 20 Tumor necrosis factor (TNF)-related apoptosis-inducing ligand PDL-1 Cgas IP10 MYD88 MSM IRFs Mx2 GALT TREX1 APOBEC HAART IFNAR ISGs pDCs interferon IFN Interleukin-10 gut-associated lymphoid tissue Gender highly active antiretroviral therapy suppressor of cytokine signaling 3 Dendritic cells plasmacytoid dendritic cells Age TRAIL macrophage inflammatory protein 3α Men who have sex with men programmed death-ligand 1 Microbiome Hepatitis C virus HCV HIV-1 Lymphocytic choriomeningitis virus myeloid differentiation primary response gene 88 protein kinase R BAK Single nucleotide polymorphism SNP janus kinase/signal transducer and activator of transcription Gut pattern recognition receptors Toll-like receptors

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Cell Biology

Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome

Authors

Carolina Scagnolari, Guido Antonelli,